全文获取类型
收费全文 | 5164篇 |
免费 | 317篇 |
国内免费 | 8篇 |
专业分类
耳鼻咽喉 | 43篇 |
儿科学 | 134篇 |
妇产科学 | 150篇 |
基础医学 | 554篇 |
口腔科学 | 69篇 |
临床医学 | 777篇 |
内科学 | 715篇 |
皮肤病学 | 155篇 |
神经病学 | 393篇 |
特种医学 | 127篇 |
外科学 | 675篇 |
综合类 | 62篇 |
一般理论 | 4篇 |
预防医学 | 799篇 |
眼科学 | 149篇 |
药学 | 402篇 |
中国医学 | 3篇 |
肿瘤学 | 278篇 |
出版年
2023年 | 37篇 |
2022年 | 40篇 |
2021年 | 118篇 |
2020年 | 67篇 |
2019年 | 115篇 |
2018年 | 111篇 |
2017年 | 110篇 |
2016年 | 107篇 |
2015年 | 127篇 |
2014年 | 175篇 |
2013年 | 265篇 |
2012年 | 385篇 |
2011年 | 400篇 |
2010年 | 208篇 |
2009年 | 178篇 |
2008年 | 318篇 |
2007年 | 344篇 |
2006年 | 321篇 |
2005年 | 315篇 |
2004年 | 299篇 |
2003年 | 277篇 |
2002年 | 253篇 |
2001年 | 67篇 |
2000年 | 52篇 |
1999年 | 53篇 |
1998年 | 55篇 |
1997年 | 42篇 |
1996年 | 40篇 |
1995年 | 46篇 |
1994年 | 32篇 |
1993年 | 25篇 |
1992年 | 40篇 |
1991年 | 47篇 |
1990年 | 45篇 |
1989年 | 33篇 |
1988年 | 31篇 |
1987年 | 24篇 |
1986年 | 24篇 |
1985年 | 25篇 |
1984年 | 34篇 |
1983年 | 23篇 |
1982年 | 15篇 |
1981年 | 12篇 |
1980年 | 21篇 |
1979年 | 15篇 |
1978年 | 13篇 |
1974年 | 9篇 |
1973年 | 11篇 |
1971年 | 14篇 |
1969年 | 8篇 |
排序方式: 共有5489条查询结果,搜索用时 93 毫秒
1.
2.
O.R. Mitchell R. Dave J. Bekker P.A. Brennan 《The British journal of oral & maxillofacial surgery》2021,59(3):384-385
The first COVID-19 vaccination was given in December 2020 and there is an effort to vaccinate the international population on a massive scale. Common side effects from the vaccine include headache and tiredness. Regional lymphadenopathy has been described in relation to other vaccines. We describe two cases of supraclavicular reactive lymphadenopathy presenting in patients who had the COVID vaccination in the ipsilateral arm. Awareness of this diagnosis is important for patients presenting to the neck lump clinic. 相似文献
3.
4.
Bernard Natukunda Grace Ndeezi Lay See Er Francis Bajunirwe Gayle Teramura Meghan Delaney 《ISBT科学丛刊》2019,14(4):366-373
5.
Rahul S. Loungani Marat Fudim Dave Ranney Ajar Kochar Marc D. Samsky Desiree Bonadonna Akinobu Itoh Hiroo Takayama Koji Takeda Daniel Wojdyla Adam D. DeVore Mani Daneshmand 《Journal of cardiac failure》2021,27(3):327-337
BackgroundVenoarterial extracorporeal membrane oxygenation (VA-ECMO) is increasingly used as a life-saving therapy for patients with cardiovascular collapse, but identifying patients unlikely to benefit remains a challenge.Methods and ResultsWe created the RESCUE registry, a retrospective, observational registry of adult patients treated with VA-ECMO between January 2007 and June 2017 at 3 high-volume centers (Columbia University, Duke University, and Washington University) to describe short-term patient outcomes. In 723 patients treated with VA-ECMO, the most common indications for deployment were postcardiotomy shock (31%), cardiomyopathy (including acute heart failure) (26%), and myocardial infarction (17%). Patients frequently suffered in-hospital complications, including acute renal dysfunction (45%), major bleeding (41%), and infection (33%). Only 40% of patients (n = 290) survived to discharge, with a minority receiving durable cardiac support (left ventricular assist device [n = 48] or heart transplantation [n = 7]). Multivariable regression analysis identified risk factors for mortality on ECMO as older age (odds ratio [OR], 1.26; 95% confidence interval [CI], 1.12–1.42) and female sex (OR, 1.44; 95% CI, 1.02–2.02) and risk factors for mortality after decannulation as higher body mass index (OR 1.17; 95% CI, 1.01-1.35) and major bleeding while on ECMO support (OR, 1.92; 95% CI, 1.23–2.99).ConclusionsDespite contemporary care at high-volume centers, patients treated with VA-ECMO continue to have significant in-hospital morbidity and mortality. The optimization of outcomes will require refinements in patient selection and improvement of care delivery. 相似文献
6.
7.
8.
Christine M Sapienza Michael P Cannito Thomas Murry Ryan Branski Gayle Woodson 《J. Speech Lang. Hear. Res.》2002,45(5):830-843
Acoustic analysis of a reading passage was used to identify the abnormal phonatory events associated with adductor spasmodic dysphonia (ADSD) pre- and postinjection of Botulinum Toxin A (Botox). Thirty-one patients (age 22 to 74 years) diagnosed with ADSD were included for study. All patients were new recipients of Botox, and the examination of their voice occurred before and after their initial injection of Botox. Acoustic events were identified from reading samples of the Rainbow Passage produced by each of the patients. These events were examined from sentences containing primarily voiced sound segments. Dependent variables included the number of phonatory breaks, frequency shifts, and aperiodic segments--all variables previously defined by the investigators. Additionally, calculated variables were made of the percentage of time these events occurred relative to the duration of the cumulative voiced segments. A sex- and age-matched control group (+/-2 years) was included for statistical comparison. Results indicated that those with ADSD produced more aberrant acoustic events than the controls. Aperiodicity was the predominant acoustic event produced during the reading, followed by frequency shifts and phonatory breaks. Within the ADSD group, the number of atypical acoustic events decreased following Botox injection. It is important that the occurrence of specific abnormal acoustic events was sufficient to differentiate the disordered speakers from the controls following as well as preceding initial Botox injection, as indicated by discriminant function analysis. This paper complements our previous work using this acoustic analysis method for defining the abnormal events present in the voice of those with ADSD and further suggests that these measures can be used in conjunction with perceptual impressions to differentiate speakers on the basis of initial severity. 相似文献
9.
The influence of protein solubilisation, conformation and size on the burst release from poly(lactide-co-glycolide) microspheres. 总被引:5,自引:0,他引:5
Gayle Duncan Thomas J Jess Farahidah Mohamed Nicholas C Price Sharon M Kelly Christopher F van der Walle 《Journal of controlled release》2005,110(1):34-48
Encapsulation of proteins in poly(lactide-co-glycolide) microspheres via emulsion is known to cause insoluble protein aggregates. Following protein emulsification and encapsulation in PLGA microspheres, we used circular dichroism to show that the recoverable soluble protein fraction also suffers subtle conformational changes. For a panel of proteins selected on the basis of molecular size and structural class, conformational stability measured by chemical denaturation was not indicative of stability during emulsion-encapsulation. Partial loss of structure was observed for alpha-helical proteins released from freeze-dried microspheres in aqueous buffer, with dramatic loss of structure for a beta-sandwich protein. The addition of sucrose (a lyoprotectant) did not prevent the loss of protein conformation upon encapsulation. Therefore, the conformational changes seen for the released soluble protein fraction originates during emulsification rather than microsphere freeze-drying. Analysis of the burst release for all proteins in buffer containing denaturant or surfactant showed that the degree of protein solubilisation was the dominant factor in determining the initial rate and extent of release. Our data for protein release into increasing concentrations of denaturing buffer suggest that the emulsion-denatured protein fraction remains insoluble; this fraction may represent the protein loss encountered upon comparison of protein encapsulated versus protein released. 相似文献
10.